International Journal of Radiation Oncology * Biology * Physics
Volume 77, Issue 1 , Pages 24-30, 1 May 2010

18F-FDG PET-CT Simulation for Non–Small-Cell Lung Cancer: Effect in Patients Already Staged by PET-CT

  • Gerard G. Hanna, M.B., M.R.C.P., F.R.C.R.

      Affiliations

    • Centre for Cancer Research and Cell Biology, Queen's University of Belfast, Belfast, Northern Ireland, United Kingdom
    • Department of Clinical Oncology, Cancer Centre, Belfast City Hospital, Belfast, Northern Ireland, United Kingdom
    • Corresponding Author InformationReprint requests to: Gerard G. Hanna, M.B., M.R.C.P., F.R.C.R., Centre for Cancer Research and Cell Biology, Queen's University of Belfast, Level 1 Cancer Centre, Belfast City Hospital, Lisburn Rd., Belfast BT9 7AB North Ireland, United Kingdom; Tel: (+44) 028-9069-9299; Fax: (+44) 028-9069-9406
  • ,
  • Jonathan McAleese, M.A., M.R.C.P., F.R.C.R.

      Affiliations

    • Department of Clinical Oncology, Cancer Centre, Belfast City Hospital, Belfast, Northern Ireland, United Kingdom
  • ,
  • Kathryn J. Carson, Ph.D.

      Affiliations

    • Northern Ireland Regional Medical Physics Agency, Royal Victoria Hospital, Belfast, Northern Ireland, United Kingdom
  • ,
  • David P. Stewart, M.B., M.R.C.P., F.R.C.R.

      Affiliations

    • Department of Clinical Oncology, Cancer Centre, Belfast City Hospital, Belfast, Northern Ireland, United Kingdom
  • ,
  • Vivian P. Cosgrove, Ph.D.

      Affiliations

    • Northern Ireland Regional Medical Physics Agency, Cancer Centre, Belfast City Hospital, Belfast, Northern Ireland, United Kingdom
  • ,
  • Ruth L. Eakin, M.B., F.R.C.P.I., F.R.C.R.

      Affiliations

    • Department of Clinical Oncology, Cancer Centre, Belfast City Hospital, Belfast, Northern Ireland, United Kingdom
  • ,
  • Ashraf Zatari, Ph.D.

      Affiliations

    • Northern Ireland Regional Medical Physics Agency, Cancer Centre, Belfast City Hospital, Belfast, Northern Ireland, United Kingdom
  • ,
  • Tom Lynch, M.B., F.R.C.R.

      Affiliations

    • Department of Nuclear Medicine, Belfast City Hospital, Belfast, Northern Ireland, United Kingdom
  • ,
  • Peter H. Jarritt, Ph.D.

      Affiliations

    • Northern Ireland Regional Medical Physics Agency, Royal Victoria Hospital, Belfast, Northern Ireland, United Kingdom
  • ,
  • V.A. Linda Young, D.C.R.

      Affiliations

    • Department of Clinical Oncology, Cancer Centre, Belfast City Hospital, Belfast, Northern Ireland, United Kingdom
  • ,
  • Joe M. O'Sullivan, M.D., F.R.C.P.I., F.F.R.R.C.S.I.

      Affiliations

    • Centre for Cancer Research and Cell Biology, Queen's University of Belfast, Belfast, Northern Ireland, United Kingdom
    • Department of Clinical Oncology, Cancer Centre, Belfast City Hospital, Belfast, Northern Ireland, United Kingdom
  • ,
  • Alan R. Hounsell, Ph.D.

      Affiliations

    • Centre for Cancer Research and Cell Biology, Queen's University of Belfast, Belfast, Northern Ireland, United Kingdom
    • Northern Ireland Regional Medical Physics Agency, Cancer Centre, Belfast City Hospital, Belfast, Northern Ireland, United Kingdom

Received 4 December 2008; received in revised form 13 April 2009; accepted 14 April 2009. published online 07 August 2009.

Purpose

Positron emission tomography (PET), in addition to computed tomography (CT), has an effect in target volume definition for radical radiotherapy (RT) for non–small-cell lung cancer (NSCLC). In previously PET-CT staged patients with NSCLC, we assessed the effect of using an additional planning PET-CT scan for gross tumor volume (GTV) definition.

Methods and Materials

A total of 28 patients with Stage IA-IIIB NSCLC were enrolled. All patients had undergone staging PET-CT to ensure suitability for radical RT. Of the 28 patients, 14 received induction chemotherapy. In place of a RT planning CT scan, patients underwent scanning on a PET-CT scanner. In a virtual planning study, four oncologists independently delineated the GTV on the CT scan alone and then on the PET-CT scan. Intraobserver and interobserver variability were assessed using the concordance index (CI), and the results were compared using the Wilcoxon signed ranks test.

Results

PET-CT improved the CI between observers when defining the GTV using the PET-CT images compared with using CT alone for matched cases (median CI, 0.57 for CT and 0.64 for PET-CT, p = .032). The median of the mean percentage of volume change from GTVCT to GTVFUSED was −5.21% for the induction chemotherapy group and 18.88% for the RT-alone group. Using the Mann-Whitney U test, this was significantly different (p = .001).

Conclusion

PET-CT RT planning scan, in addition to a staging PET-CT scan, reduces interobserver variability in GTV definition for NSCLC. The GTV size with PET-CT compared with CT in the RT-alone group increased and was reduced in the induction chemotherapy group.

Positron emission tomography, computed tomography, PET-CT, radiotherapy planning, lung cancer, non–small-cell lung cancer, NSCLC, target volume definition

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Supported by the Research and Development Office, Northern Ireland Health and Social Services.

 Conflict of interest: none.

PII: S0360-3016(09)00621-X

doi:10.1016/j.ijrobp.2009.04.045

International Journal of Radiation Oncology * Biology * Physics
Volume 77, Issue 1 , Pages 24-30, 1 May 2010